GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » EBITDA Margin %

Cresco Labs (XCNQ:CL) EBITDA Margin % : 26.08% (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cresco Labs's EBITDA for the three months ended in Mar. 2024 was C$65 Mil. Cresco Labs's Revenue for the three months ended in Mar. 2024 was C$249 Mil. Therefore, Cresco Labs's EBITDA margin for the quarter that ended in Mar. 2024 was 26.08%.


Cresco Labs EBITDA Margin % Historical Data

The historical data trend for Cresco Labs's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs EBITDA Margin % Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.93 1.10 -19.43 -1.27 -1.86

Cresco Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.12 2.93 -45.95 26.24 26.08

Competitive Comparison of Cresco Labs's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Cresco Labs's EBITDA Margin % falls into.



Cresco Labs EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Cresco Labs's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-19.259/1034.219
=-1.86 %

Cresco Labs's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=65.057/249.462
=26.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs  (XCNQ:CL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Cresco Labs EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Cresco Labs's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (XCNQ:CL) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.